I think this highlight actually reflects the delay and the fact that they are behind the timeline. Dose selection should be completed in 1H CY2023 according to their timeline, however they confirmed that they will complete recruitment for dose selection by the end of June. It will take a few more months to collect and analyze the data. I suspect we won't know the selected dose unitl the end of Q3 or maybe even Q4.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $158.8K | 780.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 165960 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 20781 | 4 |
View Market Depth
| Last trade - 14.26pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |